U.S. markets closed

ESSA Pharma Inc. (EPIX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
3.6000-0.1500 (-4.00%)
At close: 04:00PM EST
3.6000 0.00 (0.00%)
After hours: 07:59PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close3.7500
Bid3.5000 x 1000
Ask3.7100 x 800
Day's Range3.5300 - 3.7800
52 Week Range1.4000 - 14.8800
Avg. Volume3,327,419
Market Cap158.663M
Beta (5Y Monthly)2.05
PE Ratio (TTM)N/A
EPS (TTM)-0.8660
Earnings DateDec 05, 2022 - Dec 07, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est23.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for EPIX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • ESSA Pharma Inc.
    Daily – Vickers Top Buyers & Sellers for 07/21/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Fair Value
    Economic Moat
    4 months agoArgus Research
View more
  • Investopedia

    Examining Penny Stocks with Technical Analysis for December 2022

    Technical analysis (TA) involves the careful study of a stock's chart patterns and trends. Although this set of skills may seem daunting at first, even beginners can incorporate a few select TA methodologies into their investing strategy to great success.

  • Zacks Small Cap Research

    EPIX: Promising Early Data for EPI-7386 in Combination with Enzalutamide…

    By David Bautz, PhD NASDAQ:EPIX READ THE FULL EPIX RESEARCH REPORT Business Update Positive Preliminary Results from Combination Therapy of EPI-7386 and Enzalutamide On October 28, 2022, ESSA Pharma Inc (NASDAQ:EPIX) announced multiple poster presentations at the 29th Annual Prostate Cancer Foundation Scientific Retreat, including an update on the Phase 1/2 Study of EPI-7386 in combination with

  • PR Newswire

    ESSA Pharma to Participate in Two Upcoming Investor Conferences

    ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that the Company will be participating in two upcoming investor conferences.